Central nervous system fungal infections: observations from a large tertiary hospital in northern India

Prahlad K Sethi1, Laxmi Khanna, Anuradha Batra

  • 1Department of Neurology, Sir Gangaram Hospital, New Delhi, India. sethinitinmd@hotmail.com

Abstract

Insights

Fungal brain infections affect both immunocompetent and immunocompromised individuals. Early diagnosis and treatment significantly improve outcomes, with lower mortality and morbidity observed in immunocompetent patients with central nervous system fungal infections.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Mycology

Background:

  • Fungal infections of the central nervous system (CNS) pose a significant diagnostic and therapeutic challenge.
  • Understanding the spectrum and outcomes of these infections in diverse patient populations is crucial for effective management.

Purpose of the Study:

  • To investigate the clinical characteristics, treatment responses, and outcomes of CNS fungal infections.
  • To compare the presentation and prognosis of fungal infections in immunocompetent versus immunocompromised patients.

Main Methods:

  • A retrospective study of all consecutive CNS fungal infection cases over two years at a tertiary hospital in northern India.
  • Patients were classified as immunocompetent or immunocompromised, with detailed analysis of demographics, clinical presentation, radiological findings, and treatment outcomes.

Main Results:

  • Mucormycosis (50%), cryptococcosis (34%), and aspergillosis (16%) were the most common fungal CNS infections.
  • 36% of patients were immunocompromised, while 14% were immunocompetent.
  • Overall mortality was 28%, with higher rates associated with specific comorbidities and disease severity.

Conclusions:

  • CNS fungal infections occur in both immunocompetent and immunocompromised hosts.
  • Prompt diagnosis and targeted therapy are associated with favorable outcomes, particularly in immunocompetent individuals.
  • Immunocompetent patients generally experience lower mortality and morbidity from fungal brain infections.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...